EverHint – SMA 20/50 Crossover, EMA 10 + Price + MACD, EMA 10/30 Crossover – Top 39 Buy and Top 10 Sell Signals for Jun 11, 2026
Market Context
Broad equity markets are posting strong gains across all major indices, with the Nasdaq leading at +2.53% and the S&P 500 clearing +1.73%, signaling a clear risk-on environment. This kind of synchronized upside momentum is highly favorable for trend-following strategies like the SMA 20/50 and EMA 10/30 crossovers, as sustained directional moves reduce the likelihood of false crossover signals and allow positions to develop with cleaner price action. The VIX dropping sharply to 19.54 (-12.06%) confirms a meaningful compression in fear, which typically supports higher-conviction entries on breakout and momentum-based signals.
With volatility declining but still sitting above the 15–16 "calm market" threshold, intraday swings remain present enough to give MACD-based strategies meaningful momentum divergences to work with. The EMA 10 + Price + MACD combination in particular tends to perform well in this middle zone — low enough volatility to avoid excessive noise, but enough price movement to generate actionable signal separation. Traders should remain attentive to potential whipsaws near intraday highs, as sharp single-day rallies of this magnitude can occasionally trigger premature crossover signals before a trend fully consolidates.
Industrials emerging as the top sector by signal volume aligns well with the broader risk appetite on display today. Sector rotation into cyclicals like Industrials is a classic pattern during periods of improving market confidence, and it suggests institutional money may be repositioning toward growth-sensitive areas of the economy. This rotation dynamic reinforces the relevance of the 145 signals generated today, as trend-following strategies tend to capture early-stage sector momentum most effectively when volume and price direction are mutually confirming.
SMA 20/50 Crossover
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
🟢 Buy Signals (9 of 9)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | AAP | Advance Auto Parts, Inc. | Consumer Cyclical | $60.62 | $3.7B |
| 2 | ANET | Arista Networks, Inc. | Technology | $156.40 | $196.9B |
| 3 | AUB | Atlantic Union Banksha... | Financial Services | $39.50 | $5.7B |
| 4 | CNK | Cinemark Holdings, Inc. | Communication Services | $34.01 | $4.0B |
| 5 | CVBF | CVB Financial Corp. | Financial Services | $20.92 | $2.8B |
| 6 | KSS | Kohl's Corporation | Consumer Cyclical | $17.32 | $2.0B |
| 7 | MTH | Meritage Homes Corpora... | Consumer Cyclical | $73.59 | $4.9B |
| 8 | PB | Prosperity Bancshares,... | Financial Services | $71.54 | $7.2B |
| 9 | TGT | Target Corporation | Consumer Defensive | $132.64 | $60.2B |
🔴 Sell Signals (5 of 21)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | COST | Costco Wholesale Corpo... | Consumer Defensive | $975.69 | $432.7B |
| 2 | EHC | Encompass Health Corpo... | Healthcare | $102.38 | $10.2B |
| 3 | EME | EMCOR Group, Inc. | Industrials | $811.53 | $36.1B |
| 4 | EQIX | Equinix, Inc. | Real Estate | $1043.18 | $102.9B |
| 5 | ERO | Ero Copper Corp. | Basic Materials | $27.70 | $2.9B |
EMA 10 + Price + MACD
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
🟢 Buy Signals (15 of 45)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | AGNC | AGNC Investment Corp. | Real Estate | $10.30 | $11.8B |
| 2 | ALK | Alaska Air Group, Inc. | Industrials | $46.66 | $5.2B |
| 3 | ASO | Academy Sports and Out... | Consumer Cyclical | $52.33 | $3.3B |
| 4 | ATEX | Anterix Inc. | Communication Services | $81.44 | $1.5B |
| 5 | ATRO | Astronics Corporation | Industrials | $94.80 | $3.4B |
| 6 | AXGN | AxoGen, Inc. | Healthcare | $42.36 | $2.3B |
| 7 | AZN | AstraZeneca PLC | Healthcare | $182.28 | $282.7B |
| 8 | BIIB | Biogen Inc. | Healthcare | $199.96 | $29.5B |
| 9 | BMY | Bristol-Myers Squibb C... | Healthcare | $56.90 | $116.2B |
| 10 | BWXT | BWX Technologies, Inc. | Industrials | $194.68 | $17.8B |
| 11 | CAMT | Camtek Ltd. | Technology | $184.15 | $8.4B |
| 12 | CCL | Carnival Corporation &... | Consumer Cyclical | $28.12 | $39.0B |
| 13 | CRH | CRH plc | Basic Materials | $104.83 | $70.0B |
| 14 | CSL | Carlisle Companies Inc... | Industrials | $340.99 | $13.8B |
| 15 | CSX | CSX Corporation | Industrials | $47.37 | $88.0B |
EMA 10/30 Crossover
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
🟢 Buy Signals (15 of 39)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ALHC | Alignment Healthcare, ... | Healthcare | $20.24 | $4.2B |
| 2 | ALLY | Ally Financial Inc. | Financial Services | $43.49 | $13.3B |
| 3 | ANF | Abercrombie & Fitch Co. | Consumer Cyclical | $90.58 | $4.0B |
| 4 | CALM | Cal-Maine Foods, Inc. | Consumer Defensive | $79.87 | $3.8B |
| 5 | CASY | Casey's General Stores... | Consumer Cyclical | $916.28 | $34.0B |
| 6 | CB | Chubb Limited | Financial Services | $327.93 | $127.2B |
| 7 | CINF | Cincinnati Financial C... | Financial Services | $168.30 | $26.0B |
| 8 | CLX | The Clorox Company | Consumer Defensive | $98.30 | $11.9B |
| 9 | DKS | DICK'S Sporting Goods,... | Consumer Cyclical | $223.95 | $19.1B |
| 10 | DOV | Dover Corporation | Industrials | $218.53 | $29.4B |
| 11 | ECL | Ecolab Inc. | Basic Materials | $263.63 | $74.2B |
| 12 | EGP | EastGroup Properties, ... | Real Estate | $202.66 | $10.9B |
| 13 | ELS | Equity LifeStyle Prope... | Real Estate | $63.94 | $12.4B |
| 14 | EQH | Equitable Holdings, Inc. | Financial Services | $43.61 | $12.3B |
| 15 | ESE | ESCO Technologies Inc. | Technology | $315.92 | $8.2B |
🔴 Sell Signals (5 of 31)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ADTN | ADTRAN Holdings, Inc. | Technology | $15.20 | $1.2B |
| 2 | AESI | Atlas Energy Solutions... | Energy | $16.47 | $2.1B |
| 3 | AMPX | Amprius Technologies, ... | Industrials | $17.10 | $2.4B |
| 4 | AUR | Aurora Innovation, Inc. | Technology | $5.97 | $11.7B |
| 5 | AVAV | AeroVironment, Inc. | Industrials | $183.69 | $9.2B |
Field Notes
Sector concentration: Industrials (28), Technology (25), Financial Services (22)
Data coverage: 0.0% insider, 0.0% congressional, 0.0% earnings, 4.8% news
Vlad's Take
Today's signals: Strong sector concentration in Industrials (28 signals) suggests sector-specific rotation.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.